These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4197955)

  • 1. Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma.
    Sherwin AL; Wisen AA; Sokolowski CD
    Arch Neurol; 1973 Aug; 29(2):73-7. PubMed ID: 4197955
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of anticonvulsant levels in human plasma and epileptogenic brain.
    Sherwin AL; Eisen AA; Sokolowski CD
    Trans Am Neurol Assoc; 1973; 98():199-203. PubMed ID: 4784934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monitoring plasma levels of some antiepileptic drugs (phenobarbital, diphenylhydantoin, carbamazepine) in the Lennox-Gastaut syndrome and in other forms of epilepsy (partial and secondary generalized) in childhood].
    Viani F; Gerna M; Riboldi A; Rossotti V; Morselli PL
    Riv Neurol; 1975; 45(2):189-98. PubMed ID: 809828
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.
    Morselli PL; Rizzo M; Garattini S
    Ann N Y Acad Sci; 1971 Jul; 179():88-107. PubMed ID: 5285399
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbamazepine, phenytoin and phenobarbital in drug-resistant partial epilepsies.
    Cornaggia CM; Canevini MP; Giuccioli D; Pruneri C; Canger R
    Ital J Neurol Sci; 1986 Feb; 7(1):113-7. PubMed ID: 3082792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin and phenobarbitone plasma clearance during pregnancy.
    Mygind KI; Dam M; Christiansen J
    Acta Neurol Scand; 1976 Aug; 54(2):160-6. PubMed ID: 821304
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between the serum levels of phenobarbital and diphenylhydantoin and clinical data in patients with drug resistant epilepsy.
    Bendarzewska-Nawrocka B; Pietruszewska E; Bacia T
    Monogr Neural Sci; 1980; 5():229-34. PubMed ID: 7322157
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polytherapy and monotherapy in the treatment of patients with epilepsy].
    Petrone F; Cavalcanti S; Turchiaro GG; Rolando G
    Acta Neurol Quad (Napoli); 1981; 42():76-84. PubMed ID: 6791454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment of epilepsy in children up to 14 years of age].
    Borkowska Z; Mazurkowa K; Wojakowski A
    Neurol Neurochir Pol; 1971; 5(3):399-402. PubMed ID: 5000634
    [No Abstract]   [Full Text] [Related]  

  • 10. Diphenylhydantoin as an anticonvulsant: evaluation of treatment in forty mentally subnormal epileptics.
    Viukari NM
    J Ment Defic Res; 1969 Sep; 13(3):212-8. PubMed ID: 4980902
    [No Abstract]   [Full Text] [Related]  

  • 11. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat.
    Rizzo M; Morselli PL; Garattini S
    Biochem Pharmacol; 1972 Feb; 21(4):449-54. PubMed ID: 5014504
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of anticonvulsant drugs in gray and white matter of human brain.
    Harvey CD; Sherwin AL; Van Der Kleijn E
    Can J Neurol Sci; 1977 May; 4(2):89-92. PubMed ID: 404008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 14. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital.
    Vajda F; Williams FM; Davidson S; Falconer MA; Breckenridge A
    Clin Pharmacol Ther; 1974 Jun; 15(6):597-603. PubMed ID: 4841972
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation in response to anticonvulsants in a group of epileptic patients.
    Travers RD; Gallagher BB; Glaser GH
    Trans Am Neurol Assoc; 1971; 96():110-2. PubMed ID: 5159062
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation of anticonvulsant drug levels to complete seizure control.
    Feldman RG; Pippenger CE
    J Clin Pharmacol; 1976 Jan; 16(1):51-9. PubMed ID: 812890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function.
    Pratt JA; Jenner P; Johnson AL; Shorvon SD; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1984 Oct; 47(10):1131-3. PubMed ID: 6438278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of clorazepate (Tranxene) as an anticonvulsant--a pilot study.
    Troupin AS; Friel P; Wilensky AJ; Morretti-Ojemann L; Levy RH; Feigl P
    Neurology; 1979 Apr; 29(4):458-66. PubMed ID: 35767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery of temporal lobe epilepsy.
    Van Buren JM; Ajmone-Marsan C; Mutsuga N; Sadowsky D
    Adv Neurol; 1975; 8():155-96. PubMed ID: 1119353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.